BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16293676)

  • 1. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.
    Nitti D; Wils J; Dos Santos JG; Fountzilas G; Conte PF; Sava C; Tres A; Coombes RC; Crivellari D; Marchet A; Sanchez E; Bliss JM; Homewood J; Couvreur ML; Hall E; Baron B; Woods E; Emson M; Van Cutsem E; Lise M; ;
    Ann Oncol; 2006 Feb; 17(2):262-9. PubMed ID: 16293676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
    Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
    J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
    De Vita F; Giuliani F; Orditura M; Maiello E; Galizia G; Di Martino N; Montemurro F; Cartenì G; Manzione L; Romito S; Gebbia V; Ciardiello F; Catalano G; Colucci G;
    Ann Oncol; 2007 Aug; 18(8):1354-8. PubMed ID: 17525087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
    Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P
    J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG).
    Songun I; Keizer HJ; Hermans J; Klementschitsch P; de Vries JE; Wils JA; van der Bijl J; van Krieken JH; van de Velde CJ
    Eur J Cancer; 1999 Apr; 35(4):558-62. PubMed ID: 10492627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
    Webb A; Cunningham D; Scarffe JH; Harper P; Norman A; Joffe JK; Hughes M; Mansi J; Findlay M; Hill A; Oates J; Nicolson M; Hickish T; O'Brien M; Iveson T; Watson M; Underhill C; Wardley A; Meehan M
    J Clin Oncol; 1997 Jan; 15(1):261-7. PubMed ID: 8996151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial.
    Waters JS; Norman A; Cunningham D; Scarffe JH; Webb A; Harper P; Joffe JK; Mackean M; Mansi J; Leahy M; Hill A; Oates J; Rao S; Nicolson M; Hickish T
    Br J Cancer; 1999 Apr; 80(1-2):269-72. PubMed ID: 10390007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
    Kelsen D; Atiq OT; Saltz L; Niedzwiecki D; Ginn D; Chapman D; Heelan R; Lightdale C; Vinciguerra V; Brennan M
    J Clin Oncol; 1992 Apr; 10(4):541-8. PubMed ID: 1548519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma.
    Cocconi G; Carlini P; Gamboni A; Gasperoni S; Rodinò C; Zironi S; Bisagni G; Porrozzi S; Cognetti F; Di Costanzo F; Canaletti R; Ruggeri EM; Camisa R; Pucci F;
    Ann Oncol; 2003 Aug; 14(8):1258-63. PubMed ID: 12881389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer.
    Chang HM; Jung KH; Kim TY; Kim WS; Yang HK; Lee KU; Choe KJ; Heo DS; Bang YJ; Kim NK
    Ann Oncol; 2002 Nov; 13(11):1779-85. PubMed ID: 12419751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
    Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
    J Clin Oncol; 1996 Jun; 14(6):1818-28. PubMed ID: 8656250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.
    Pyrhönen S; Kuitunen T; Nyandoto P; Kouri M
    Br J Cancer; 1995 Mar; 71(3):587-91. PubMed ID: 7533517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer.
    Roelofs EJ; Wagener DJ; Conroy T; Wils J; Burghouts JT; Fickers M; de Graeff A; Lalisang F; Paillot B
    Ann Oncol; 1993 May; 4(5):426-8. PubMed ID: 8353077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adjuvant chemotherapy cycles on prognosis of resectable stomach cancer: a retrospective analysis.
    Zhang WY; Zhang WJ; Bai Y; Yuan HH; Liu F; Gao J; Gong YF; Jiang B
    Asian Pac J Cancer Prev; 2013; 14(1):381-6. PubMed ID: 23534757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.
    Hartgrink HH; van de Velde CJ; Putter H; Songun I; Tesselaar ME; Kranenbarg EK; de Vries JE; Wils JA; van der Bijl J; van Krieken JH;
    Eur J Surg Oncol; 2004 Aug; 30(6):643-9. PubMed ID: 15256239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
    Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
    J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study.
    Macdonald JS; Fleming TR; Peterson RF; Berenberg JL; McClure S; Chapman RA; Eyre HJ; Solanki D; Cruz AB; Gagliano R
    Ann Surg Oncol; 1995 Nov; 2(6):488-94. PubMed ID: 8591078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.
    Wils JA; Klein HO; Wagener DJ; Bleiberg H; Reis H; Korsten F; Conroy T; Fickers M; Leyvraz S; Buyse M
    J Clin Oncol; 1991 May; 9(5):827-31. PubMed ID: 2016625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.